Abstract
568 Background: While urban-rural differences in cancer care are well described, the etiology for such disparities is unclear. Our aim was to determine whether differences in AC use are mediated through variations in community size (CS) and whether differences in AC use translated into differences in patient survival outcomes (SO). Methods: Patients with stage II/III RC from 1999 to 2009 and referred to any 1 of 5 regional cancer centers in British Columbia were reviewed. Communities were classified as rural (R), small urban (SU), moderate urban (MU), and large urban (LU) based on census data. Using zip codes and a distance matrix application interface, driving distance (DD) to patients’ respective cancer center (CC) was determined and categorized into quartiles. Stepwise logistic regression was used to explore AC use based on urban-rural communities, controlling for DD. Cox regression was used to identify whether variations in CS translated into differences in SO. Results: A total of 2618 patients were identified: median age 67 years (IQR 58-75), 64% men, and 63% received AC. Patients were distributed across various communities: R 37%; SU 11%; MU 13%; and LU 39%. There were no differences in baseline characteristics based on CS (all p<0.05). Compared to patients in LU centers, those living in R, SU and MU areas were less likely to be treated with AC (55 % vs. 49% vs. 71%, respectively, p<0.001). Likewise, DD was shortest for LU and longest for R residents (p<0.001). In multivariate analysis that controlled for confounders, urban-rural disparities in receipt of AC persisted, and these differences were significantly increased after adjusting for DD (Table). In Cox regression analysis which controlled for confounders, patients who lived in R, SU, and MU regions did not have a significantly inferior SO in comparison to those living in LU areas (HR: 0.926, 0.813, 1.006, respectively, p=0.47). Conclusions: There are urban-rural disparities in access to AC independent of patients’ DD to CC. These disparities do not seem to alter patients’ SO. [Table: see text]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.